Cleveland Biolabs (CBLI) Reports Q1 Loss of $0.06/Share
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Total other (income)/expense: 1.85M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Financial Fact:
Total other (income)/expense: 1.85M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q1 EPS of ($0.06), versus ($1.14) reported last year. Revenue for the quarter came in at $12.5 thousand, versus $607.3 thousand reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean (RCL) Tops Q1 EPS by 45c, Misses on Revenue; Offers FY24 EPS Guidance
- Mobileye (MBLY) misses estimates for Q1 earnings, revenue; shares slip
- Wex, Inc. (WEX) Misses Q1 EPS by 2c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
